What happens if you stop? Maintenance and GLP-1s

One of the most important — and least advertised — facts about GLP-1 treatment is what happens when it stops. Understanding it up front changes how you think about the whole journey, from a sprint into a plan.

Why the weight tends to return

The medicines work by steadying an appetite signal. When you stop, that signal returns to where your biology sets it — and for many people, so does some of the appetite and weight. In the STEP 1 trial extension, participants regained a large share of the weight they had lost in the year after stopping semaglutide, and some of the metabolic improvements reversed too. This is not a personal failure; it is how the underlying condition behaves.

Obesity as a chronic condition

That regain is exactly why clinicians increasingly frame obesity like other chronic conditions — closer to blood pressure or blood sugar than to a temporary problem you fix once. You would not expect blood pressure to stay controlled after stopping the medicine that controls it; weight often behaves the same way.

What a durable plan looks like

None of this means treatment is pointless — it means it needs a maintenance plan rather than an abrupt finish. Depending on the person, that can involve:

• staying on a maintenance dose under ongoing review;
• a gradual, physician-guided taper rather than stopping cold;
• doubling down on the habits — protein, resistance training, sleep, activity — that carry more of the load once the dose is lower.

The honest version

GLP-1 medication is a powerful tool, not a one-time cure. Going in with realistic expectations about maintenance — and a care team who plans for it with you — is what turns short-term loss into lasting change. Results vary, and any decision to continue, adjust, or stop is one to make with your physician.